Renovis Surgical received FDA 510(k) clearance to market the Tesera™ SC porous titanium cervical interbody fusion system.
The standalone system, like all Tesera implants, is fabricated via additive manufacturing (3D printing) to create a highly-porous surface structure.
Source: Renovis Surgical Technologies, Inc.
This is the fourth product group featuring Tesera porous titanium for which Renovis has received FDA clearance, following:
- Tesera SA for standalone anterior spinal fusion (cleared 3Q13)
- Tesera Acetabular for adult reconstruction (cleared 2Q14)
- Tesera Posterior Lumbar Interbody (cleared 1Q15)
Renovis Surgical received FDA 510(k) clearance to market the Tesera™ SC porous titanium cervical interbody fusion system.
The standalone system, like all Tesera implants, is fabricated via additive manufacturing (3D printing) to create a highly-porous surface structure.
Source: Renovis Surgical Technologies, Inc.
This is the fourth...
Renovis Surgical received FDA 510(k) clearance to market the Tesera™ SC porous titanium cervical interbody fusion system.
The standalone system, like all Tesera implants, is fabricated via additive manufacturing (3D printing) to create a highly-porous surface structure.
Source: Renovis Surgical Technologies, Inc.
This is the fourth product group featuring Tesera porous titanium for which Renovis has received FDA clearance, following:
- Tesera SA for standalone anterior spinal fusion (cleared 3Q13)
- Tesera Acetabular for adult reconstruction (cleared 2Q14)
- Tesera Posterior Lumbar Interbody (cleared 1Q15)
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.